CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $67,090 | +31.5% | 3,607 | -10.9% | 0.00% | +200.0% |
| Q3 2022 | $51,000 | -23.9% | 4,048 | -57.4% | 0.00% | 0.0% |
| Q2 2022 | $67,000 | +63.4% | 9,508 | +91.5% | 0.00% | – |
| Q1 2022 | $41,000 | -10.9% | 4,965 | -26.6% | 0.00% | – |
| Q4 2021 | $46,000 | -9.8% | 6,762 | -29.3% | 0.00% | – |
| Q3 2021 | $51,000 | -53.6% | 9,561 | -49.8% | 0.00% | -100.0% |
| Q2 2021 | $110,000 | – | 19,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |